Physician profile
Ramona S Wright
NPI 1235381666
$1,761.07
in general payments reported to CMS, 2019-2025
14 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $268 · 2022: $860 · 2023: $128 · 2024: $36.81 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $268.27 | 2022 | |
| Abbvie INC. | $251.39 | 2022-2023 | |
| Glaxosmithkline, LLC. | $229.91 | 2021-2022 | |
| Novo Nordisk INC | $171.25 | 2025 | |
| Edwards Lifesciences Corporation | $165.49 | 2025 | Sapien 3 Ultra Resilia |
| Biotronik Nro, INC. | $132.16 | 2025 | Prospera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.00 | 2022 | |
| Abbott Laboratories | $94.31 | 2022 | |
| Sunovion Pharmaceuticals INC. | $79.88 | 2021 | |
| Gilead Sciences, INC. | $68.13 | 2022 | |
| Idorsia Pharmaceuticals US INC | $57.40 | 2022 | |
| Merck Sharp & Dohme LLC | $56.24 | 2021-2024 | Capvaxive, Gardasil, Gardasil 9 |
| Amarin Pharma, INC. | $41.81 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.83 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramona Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.